Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization

NCT00396760 is registered in ClinicalTrials.gov with German Heart Center as lead sponsor.

NCT NCT00396760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization
Lead sponsor
German Heart Center
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2005
Completion date
July 31, 2006
Enrollment
220
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic blood transfusion, aortic valve replacement, bleeding and cardiac surgery, coronary artery bypass graft surgery